Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Novavax Is No Longer Expected To Become Profitable This Year — Is It A Sell?
01:09pm, Friday, 13'th Sep 2024
Is Novavax stock a sell after its second-quarter disappointment led to a guidance cut? NVAX stock ranks low among biotechs.
Is Novavax Stock A Buy Or A Sell In September 2024 On A Mixed Earnings Report?
01:09pm, Friday, 13'th Sep 2024
Novavax stock rose on its strong earnings, though sales came in light and the company cut its outlook. Is NVAX stock a buy or a sell?
Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.
09:25am, Friday, 13'th Sep 2024
Doses of Novavax's 2024-2025 Formula COVID-19 vaccine now available at thousands of locations nationwide Novavax's updated vaccine is the only protein-based option available in the U.S. this fall for
Should You Buy Novavax Stock After This Regulatory Win?
07:50am, Friday, 13'th Sep 2024
Novavax received emergency use authorization for an updated vaccine. The biotech is benefiting from a partnership with Sanofi.
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Wednesday, 11'th Sep 2024
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax, Inc. (NVAX) Baird 2024 Global Healthcare Conference (Transcript)
05:52pm, Tuesday, 10'th Sep 2024
Novavax, Inc. (NASDAQ:NVAX ) Baird 2024 Global Healthcare Conference September 10, 2024 3:10 PM ET Unidentified Company Representative I'd like to thank you all for joining us for Novavax Corporate pr
Novavax, Inc. (NVAX) H.C. Wainwright 26th Annual Global Investment Conference (Transcript)
06:59pm, Monday, 09'th Sep 2024
Novavax, Inc. (NASDAQ:NVAX ) H.C. Wainwright 26th Annual Global Investment Conference September 9, 2024 3:30 PM ET Company Participants Jim Kelly - CFO Bob Walker - Head of R&D Conference Call Partici
Could This Be the Catalyst Novavax Needs to Get Its Stock Rallying Again?
10:00am, Thursday, 05'th Sep 2024
Novavax's stock has been surging this year after announcing news of a collaboration with Sanofi. The company recently reported a profit, but whether it can stay out of the red is still a big question
Novavax to Participate in Upcoming September Conferences
09:25am, Wednesday, 04'th Sep 2024
GAITHERSBURG, Md. , Sept. 4, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that it will part
Novavax Stock Up 9% on FDA Nod for Updated COVID-19 Vaccine
12:17pm, Monday, 02'nd Sep 2024
The FDA authorization for NVAX's updated COVID-19 vaccine makes it the only non-mRNA vaccine option in the country.
Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
03:46pm, Friday, 30'th Aug 2024
Novavax expects pre-filled syringes will be broadly available in thousands of locations across the U.S. Novavax's vaccine is the only protein-based option available in the U.S. for use in individuals
FDA authorizes Novavax's updated Covid vaccine, paving way for fall rollout
03:29pm, Friday, 30'th Aug 2024
The Food and Drug Administration authorized Novavax's new protein-based Covid vaccine for emergency use in people ages 12 and up. Novavax's vaccine targets the highly contagious omicron subvariant JN.
FDA authorizes Novavax's updated COVID vaccine targeting JN.1 strain
02:38pm, Friday, 30'th Aug 2024
The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID shot.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:05am, Wednesday, 28'th Aug 2024
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?
11:20am, Saturday, 24'th Aug 2024
Novavax's shares are up significantly in 2024. The biotech's upcoming clinical trials could provide another boost.
